Electrophoresis Market By Product (Instruments {Gel Electrophoresis Systems, Capillary Electrophoresis Systems}, Reagents {Protein Electrophoresis Reagents, Nucleic Acid Electrophoresis Reagents}, Gels, Software & Services), By Technique (Gel Electrophoresis, Capillary Electrophoresis, Microfluidic Electrophoresis), By Application (Research, Diagnostics, Quality Control & Process Validation, Others), By End-user (Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Forensic Laboratories, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

What trends will shape the Electrophoresis Market in the coming years?

The Electrophoresis Market accounted for USD 3.26 Billion in 2024 and USD 3.45 Billion in 2025 is expected to reach USD 6.0 Billion by 2035, growing at a CAGR of around 5.71% between 2025 and 2035. The Electrophoresis Market is concerned with methods in biomolecule separation, like DNA, RNA, and proteins, based on size and charge in the presence of an electric field. It plays crucial roles in genomics, proteomics, drug development, and diagnostics.

The notable patterns and developments in this market are the growing use of capillary electrophoresis, the demand for personalized medicine, the improvement of gel documentation systems, and the automation of laboratory processes. Investments in biotechnology research are increasing rapidly, and a number of diagnostic labs are being established across the world, which are fueling growth. Combining them with AI and lab-on-a-chip technologies may offer a major efficiency and throughput increase in the future. 

What do industry experts say about the Electrophoresis Market trends?

“We work on capillary electrophoresis, focused on developing the instrumentation to increase throughput for single-cell analysis or chemical cytometry.”

• Nancy Allbritton, UNC & NC State University

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the Electrophoresis Market?

Is the rising demand for genomics research accelerating market expansion globally?

The Electrophoresis Market is also growing increasingly high because of the growing interest of the world in genomics research. As the information on the topic of personalized medicine, pharmacogenomics, and disease diagnostics is growing, researchers have been using the methods of DNA and RNA separation extensively to decode genetic information. Gel and capillary electrophoresis are fundamental in the analysis of genetic sequences, mutation identification, as well as mapping of genomes. Molecular research has already enjoyed significant foundation with large-scale projects such as the Human Genome Project, and the trends will only compound with government funding and corporate investments in genomics. Another area where electrophoresis has found its way into the R&D workflow of biopharma companies is genetic profiling, where there is a need to be certain that the results are accurate.

High-resolution data that is produced by the technique necessitates its skill in this field. Furthermore, access to the field of genomics has been widened by the fact that reagents and kits are now affordable. Genetic testing facilities in Asia and Europe, as well as academic research institutions, are on an expansion spree in terms of electrophoresis operations. Around the world, these micro-Labs are enhanced by the installation of 20,000+ electrophoresis instruments in more than 120 nations (including 6000+ HYDRASYS 2 Scan), a fact that indicates the significant penetration as well as long-term demand in research and diagnostics.

Will increased funding in biotech R&D drive electrophoresis adoption?

Investment in biotechnology research and development around the world is one of the fundamental drivers of the growth of the Electrophoresis Market. With the potential of biotechnology in healthcare, agriculture, and the environment, resources have been heavily increased, as governments and individual companies are supporting and investing in biotechnology. Such investments are frequently aimed at the development of an infrastructure, discovery of new drugs, and diagnostics, all of which cannot be completed without the availability of electrophoresis as a means of molecular analysis. Drug companies, both pharmaceutical and biotechnology, are taking on more complex electrophoresis systems to perform protein and nucleic acid analysis, to be analyzed quickly and more precisely at the preclinical and clinical phases of drug development.

Electrophoresis gear is being bought by universities and academic institutions on national grants, increasing laboratory research capabilities. Moreover, biotech incubators and startups are turning toward electrophoresis to confirm their results and retain reproducibility at their initial stages of invention. An illustration of such high throughput capacity is that of the Wellcome Sanger Institute, which works with close to 10 billion bases of DNA per day, as well as capillary and other sequencing mechanisms-evidence of the extent to which the electrophoresis technologies are being applied in the field of genomics. This was a widespread funding that, in turn, provides an incentive to reduce the barrier of funding and obtaining newer, automated systems. The development of new economies is also reflected in the emergence of a number of biotech research grants, like India and Brazil, that help in expanding the market regionally.

Do high instrument costs limit electrophoresis adoption in small labs?

For the Electrophoresis Market, the high cost of the instruments is one of the main challenges facing the market since most of these institutions and facilities have a limited budget and hence cannot afford these instruments. Although the technique of electrophoresis is powerful and widely practiced, its advanced versions, particularly the capillary electrophoresis ward and automated gel documentation units, have high capital investments. These systems are costly to many of the smaller labs in developing regions or even rural areas, and thus limit their capacity to carry out high-precision molecular analysis. Cost of maintenance and calibration also contributes to the cost of operation, and thus, it becomes a strain on the budget-conscious users in the long run.

These constraints result in a technological disparity between financed research centers and those where the health care or research center is small. Consequently, some labs fail to procure or just use out-of-date, less efficient systems. In most cases, regardless of the availability of grants, it is rare that the grants will be adequate to purchase the needed equipment, as well as additional consumables needed. This is a cost barrier that not only inhibits innovation but also limits the democratization of advanced molecular diagnostics. The Electrophoresis Market needs to fill this gap by motivating the manufacturers to produce not only less expensive but also modular systems or offer leasing solutions to individual buyers with low volumes.

Can microfluidics integration transform point-of-care diagnostic applications?

The Electrophoresis Market will stand to gain a lot with the incorporation of microfluidic applications, especially in point-of-care testing. Microfluidic electrophoresis Minim Agents of traditional separation processes on a chip, allowing reduction of sample volume, time, and reagents, as well as portability and automation. Such transformation is particularly useful in rural/resource-short healthcare facilities where the conventional laboratory infrastructure is lacking. Using microfluidic chips with electrophoresis capabilities, one can quickly analyse DNA, RNA, and proteins, thus detecting diseases quickly as well as infectious agents and genetic diseases.

Lab-on-a-chip devices are currently being investigated as a way of making diagnostics more affordable and quicker by start-ups and research groups. Such portable systems allow real-time bedside molecular diagnostics in hospitals and emergency response units. Also, microfluidics integrated with data readouts via smartphones and analysis in the cloud increases the usability and management of patient data. The innovation not only enhances efficiency but also allows electrophoresis to spread out of labs and into clinics, homes, and field settings. As decentralized testing becomes a valued alternative to the rest of the healthcare ecosystem, microfluidic adaptation could grant the Electrophoresis Market quite a stimulus.

Will AI-powered software enhance gel documentation and result interpretation?

The AI integration has become the prospect of change in the Electrophoresis Market, especially in increasing the level of gel documentation and data interpretation. Depending on manual interpretation, traditional electrophoresis, particularly when used with gels, is time-consuming and subjective. Nonetheless, band detection, molecular weight measurements, and batch generation of standard reports can be automated by the use of AI-driven software with better accuracy and reproducibility. These smart systems minimize human errors, speed up the processing period, and, finally, enable the uniform writing of notes throughout the experiments.

In addition, the AI technologies can be conditioned to identify minor alterations in patterns, which is why they would be especially applicable in the clinical and forensics sectors. Cloud-based platforms also make it such that electrophoresis results can be viewed globally, when not physically present. Such AI-supported tools can be used in research and diagnostics to smooth the process, particularly in high-throughput laboratories that handle thousands of samples per week. Major organizations already have machine learning codes built into gel imaging systems to provide predictive analytics and quality control. It is believed that the Electrophoresis Market will grow in the use of these digital tools, which is a trend of smart lab automation.

What are the key market segments in the Electrophoresis industry?

Based on the Product, the Electrophoresis Market has been classified into Instruments, Reagents, Gels, Software & Services. Instruments dominate the business category in the Electrophoresis Market and are owed to the popular use of the gel and capillary electrophoresis systems in research and diagnosis. There is a wide adoption of gel electrophoresis systems because they are affordable and most reliable in the analysis of nucleic acids and proteins.

In the meantime, high-resolution separation and automation capabilities are making capillary electrophoresis systems popular. Reagents are also important, especially the protein and nucleic acid electrophoresis reagents, since there is always a repetition of the laboratory requirement. The Gels and Software and Services divisions assist system operation and data analysis interpretation, and their role is expanding in the advanced lab practices.

Based on the Technique, the Electrophoresis Market has been classified into Gel Electrophoresis, Capillary Electrophoresis, and Microfluidic Electrophoresis. Gel Electrophoresis is the most widely used in the Electrophoresis Market due to its ease of use, low cost, and high completeness in use in genomics, proteomics, and forensics. It is still a staple in higher learning institutions and research centers to perform everyday molecular biology experiments.

The use of Capillary Electrophoresis is growing at a high rate because of its automated capability, increased sensitivity, application in clinical monitoring, and in evaluating pharmaceutical quality. Microfluidic Electrophoresis becomes a promising solution of the futuristic kind with plenty of applications in point-of-care testing and lab-on-chip platforms, but it is marked by barriers to adoption. The tendency to switch to more advanced methods will be gradual as long as the technological innovations continue, yet as of now, gel electrophoresis is still in the lead.

Which regions are leading the Electrophoresis Market, and why?

The North America Electrophoresis Market is witnessing the highest share due to its being most established in the biotechnology and pharmaceutical industry, with robust academic research facilities and government and non-government investment in molecular diagnosis. The U.S. has been at the forefront in the adoption of the advanced electrophoresis apparatus in the field of genomics and proteomics research.

The area has been able to take advantage of the fact that large market participants are present with constant R&D, and an increased amount of use in personalized medicine and forensic science. Moreover, legal aid and technological advances also precondition a strong position on the market. Markets in North American research institutions and clinical laboratories will continue to have high demands for automated as well as high-throughput electrophoresis systems.

The Asia-Pacific Electrophoresis Market is fast developing due to the growth in investments in the science of biotechnology, growth in the healthcare infrastructure, and growing research in nations such as China, India, and South Korea. Demand for molecular diagnostics, especially in the detection of cancer and infection, is skyrocketing in the region.

The increasing use of electrophoresis systems is being stimulated by government efforts to increase genomic studies alongside rising drug manufacturing. Accessibility and market penetration are also driven by localized manufacture of low-cost instruments and reagents. The region is projected to follow its current high rate of growth as long as it focuses on R&D and technological improvement.  

What does the competitive landscape of the Electrophoresis Market look like?

The global Electrophoresis Market is highly competitive with a number of global and regional players engaged in the areas of product advancement, constant innovation, and strategic partnership. The major market competitors are Thermo Fisher Scientific, Bio-Rad Laboratories, Agilent Technologies, Merck KGaA, QIAGEN, PerkinElmer, and GE Healthcare. In a bid to produce state-of-the-art, computerized electrophoresis machines, these organizations are spending a lot of money on research and development to come up with better machines that are accurate and have better throughput. The main strategies of reaching the market and developing technological capacities still rest on product launches, mergers, and acquisitions.

As an example, Thermo Fisher and Bio-Rad are still releasing short systems that are complemented by software packages in order to complete faster and more efficient workflows. Agilent and QIAGEN are this differentiation utilizing AI and microfluidics to differentiate. These companies are also partnering with universities and biotechnology companies, which enables them to keep in line with the ever-changing research demands. In addition, a number of players are also aiming at emerging markets in Asia-Pacific by localizing manufacturing and distribution networks. Other critical strategies that are being pursued to ensure leadership and subsequent growth in the highly dynamic electrophoresis market include competitive pricing, strengthening of customer support, and portfolio diversification.

Electrophoresis Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the Electrophoresis industry?

• In May 2025, Thermo Fisher Scientific launched the Applied Biosystems SeqStudio Flex Dx, an IVDR‑compliant capillary electrophoresis genetic analyzer available in 8‑ and 24‑capillary configurations, supporting multiple modes (IVD, research, investigational) and featuring high throughput and auto‑calibration functions
• In January 2025, Bio‑Rad Laboratories introduced an automated electrophoresis platform with real‑time AI‑driven data analysis designed to improve efficiency in clinical diagnostics and genomic research

Report Coverage:

By Product

• Instruments
  • Gel Electrophoresis Systems
  • Capillary Electrophoresis Systems
• Reagents
  • Protein Electrophoresis Reagents
  • Nucleic Acid Electrophoresis Reagents
• Gels
• Software & Services

By Technique

• Gel Electrophoresis
• Capillary Electrophoresis
• Microfluidic Electrophoresis

By Application

• Research
• Diagnostics
• Quality Control & Process Validation
• Others

By End-user

• Academic & Research Institutions
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Forensic Laboratories

• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Agilent Technologies
• Merck KGaA
• GE Healthcare
• QIAGEN N.V.
• PerkinElmer Inc.
• Harvard Bioscience
• Lonza Group AG
• Danaher Corporation
• Analytik Jena AG
• Sebia Group
• Shimadzu Corporation
• Hitachi High-Tech Corporation
• Helena Laboratories

Frequently Asked Questions (FAQs)